New hope for stuffy noses: experimental drug targets nasal polyps
NCT ID NCT06639295
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests an investigational drug called 611 in 243 adults with chronic sinusitis and nasal polyps that haven't been well-controlled by other treatments. The goal is to see if 611 can shrink polyps and ease nasal congestion over 24 weeks. Participants receive either the drug or a placebo, and neither they nor their doctors know which they get.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NASAL POLYPS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Site 01
Beijing, Beijing Municipality, 100730, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A gentle touch against coughs and colds: could manual therapy shorten respiratory illness?
- Can a drug that calms inflammation ease chronic sinusitis?
- Antibiotics vs. placebo for Kids' sinus infections: which works best?
- Can an asthma drug shrink nasal polyps? a major trial seeks answers
- Can a single drug shrink nasal polyps and restore breathing?
- Nanoparticle steroid spray could transform recovery after sinus surgery